Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helge Taubert

Showing results (91-100 of 168) with videos related to

Pageof 17
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 14, 2003
Loss of heterozygosity at 12q14-15 often occurs in stage I soft tissue sarcomas and is associated with MDM2 amplification in tumors at various stagesHelge Taubert, Katja Schuster, Ulrich Brinck, et al.
Journal of Cancer Research and Clinical Oncology|March 4, 2015
Functional analyses and prognostic significance of SFRP1 expression in bladder cancerAnja Rogler, Emil Kendziorra, Johannes Giedl, et al.
Endocrinology|September 10, 2024
MED12 and CDK8/19 Modulate Androgen Receptor Activity and Enzalutamide Response in Prostate CancerChiara Andolfi, Caterina Bartolini, Elisa Morales, et al.
Molecular Cancer Research : MCR|October 17, 2008
Association of HDM2 transcript levels with age of onset and prognosis in soft tissue sarcomasHelge Taubert, Frank Bartel, Thomas Greither, et al.
Urologia Internationalis|July 5, 2016
How Octogenarians with Bladder Cancer Are Treated in a Maximum-Care Hospital: The Real-Life ExperienceDanijel Sikic, Sven Wach, Helge Taubert, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|May 23, 2015
Frequency of TERT Promoter Mutations in Prostate CancerRobert Stoehr, Helge Taubert, Ulrike Zinnall, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 30, 2008
Immunohistochemical detection of HIF-1alpha and CAIX in advanced head-and-neck cancer. Prognostic role and correlation with tumor markers and tumor oxygenation parametersMatthias Kappler, Helge Taubert, Hans-Jürgen Holzhausen, et al.
Cancers|October 2, 2020
Analysis of CXCL9, PD1 and PD-L1 mRNA in Stage T1 Non-Muscle Invasive Bladder Cancer and Their Association with PrognosisJennifer Kubon, Danijel Sikic, Markus Eckstein, et al.
Plos One|June 21, 2017
Immunohistochemiocal subtyping using CK20 and CK5 can identify urothelial carcinomas of the upper urinary tract with a poor prognosisDanijel Sikic, Bastian Keck, Sven Wach, et al.
BMC Cancer|June 28, 2011
Combined mRNA expression levels of members of the urokinase plasminogen activator (uPA) system correlate with disease-associated survival of soft-tissue sarcoma patientsMatthias Kotzsch, Viktor Magdolen, Thomas Greither, et al.
Pageof 17

Showing results (91-100 of 168) with videos related to

Sort By:
Pageof 17
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 14, 2003
Loss of heterozygosity at 12q14-15 often occurs in stage I soft tissue sarcomas and is associated with MDM2 amplification in tumors at various stagesHelge Taubert, Katja Schuster, Ulrich Brinck, et al.
Journal of Cancer Research and Clinical Oncology|March 4, 2015
Functional analyses and prognostic significance of SFRP1 expression in bladder cancerAnja Rogler, Emil Kendziorra, Johannes Giedl, et al.
Endocrinology|September 10, 2024
MED12 and CDK8/19 Modulate Androgen Receptor Activity and Enzalutamide Response in Prostate CancerChiara Andolfi, Caterina Bartolini, Elisa Morales, et al.
Molecular Cancer Research : MCR|October 17, 2008
Association of HDM2 transcript levels with age of onset and prognosis in soft tissue sarcomasHelge Taubert, Frank Bartel, Thomas Greither, et al.
Urologia Internationalis|July 5, 2016
How Octogenarians with Bladder Cancer Are Treated in a Maximum-Care Hospital: The Real-Life ExperienceDanijel Sikic, Sven Wach, Helge Taubert, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|May 23, 2015
Frequency of TERT Promoter Mutations in Prostate CancerRobert Stoehr, Helge Taubert, Ulrike Zinnall, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 30, 2008
Immunohistochemical detection of HIF-1alpha and CAIX in advanced head-and-neck cancer. Prognostic role and correlation with tumor markers and tumor oxygenation parametersMatthias Kappler, Helge Taubert, Hans-Jürgen Holzhausen, et al.
Cancers|October 2, 2020
Analysis of CXCL9, PD1 and PD-L1 mRNA in Stage T1 Non-Muscle Invasive Bladder Cancer and Their Association with PrognosisJennifer Kubon, Danijel Sikic, Markus Eckstein, et al.
Plos One|June 21, 2017
Immunohistochemiocal subtyping using CK20 and CK5 can identify urothelial carcinomas of the upper urinary tract with a poor prognosisDanijel Sikic, Bastian Keck, Sven Wach, et al.
BMC Cancer|June 28, 2011
Combined mRNA expression levels of members of the urokinase plasminogen activator (uPA) system correlate with disease-associated survival of soft-tissue sarcoma patientsMatthias Kotzsch, Viktor Magdolen, Thomas Greither, et al.
Pageof 17